CD274 and neoplasm: Consistent with the observation of increased PD-L1 observed in melanoma patients receiving oncolytic HSV virotherapy10, HSVQ virus infection of tumor cells revealed an induction of cell-surface PD-L1 expression on 3 of 4 breast cancer cell lines tested.